IL-12 lipid nanoparticles provoked the infiltration of activated CD44+CD3+CD4+ T cells into tumor and enhanced IFN-γ production suggesting that IL-12 LNP can serve as an effective immunotherapy against HCC [127]. This evidence concerns the gene CD44 and hepatocellular carcinoma.